Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 699

1.

Association of a LSP1 gene rs3817198T>C polymorphism with breast cancer risk: evidence from 33,920 cases and 35,671 controls.

Chen MB, Li C, Shen WX, Guo YJ, Shen W, Lu PH.

Mol Biol Rep. 2011 Oct;38(7):4687-95. doi: 10.1007/s11033-010-0603-3. Epub 2010 Dec 2.

PMID:
21127985
2.

Association between mitogen-activated protein kinase kinase kinase 1 rs889312 polymorphism and breast cancer risk: evidence from 59,977 subjects.

Lu PH, Yang J, Li C, Wei MX, Shen W, Shi LP, Jiang ZY, Zhou N, Tao GQ.

Breast Cancer Res Treat. 2011 Apr;126(3):663-70. doi: 10.1007/s10549-010-1151-1. Epub 2010 Sep 1.

PMID:
20809358
3.

MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.

Zhang J, Qiu LX, Wang ZH, Wu XH, Liu XJ, Wang BY, Hu XC.

Breast Cancer Res Treat. 2010 Sep;123(2):549-55. doi: 10.1007/s10549-010-0783-5. Epub 2010 Feb 9.

PMID:
20143151
4.

Association of 8q24 rs13281615A > G polymorphism with breast cancer risk: evidence from 40,762 cases and 50,380 controls.

Dai G, Guo Z, Yang X, Yu B, Li L.

Mol Biol Rep. 2013 Jun;40(6):4065-73. doi: 10.1007/s11033-012-2484-0. Epub 2013 Jan 5.

PMID:
23292077
5.

Association of STXBP4/COX11 rs6504950 (G>A) polymorphism with breast cancer risk: evidence from 17,960 cases and 22,713 controls.

Tang L, Xu J, Wei F, Wang L, Nie WW, Chen LB, Guan XX.

Arch Med Res. 2012 Jul;43(5):383-8. doi: 10.1016/j.arcmed.2012.07.008. Epub 2012 Aug 3.

PMID:
22863968
6.

Association between two polymorphisms of ABCB1 and breast cancer risk in the current studies: a meta-analysis.

Lu PH, Wei MX, Yang J, Liu X, Tao GQ, Shen W, Chen MB.

Breast Cancer Res Treat. 2011 Jan;125(2):537-43. doi: 10.1007/s10549-010-1033-6. Epub 2010 Jul 13.

PMID:
20625815
7.

Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis.

Zhou L, Yao F, Luan H, Wang Y, Dong X, Zhou W, Wang Q.

Breast Cancer Res Treat. 2012 Dec;136(3):885-97. doi: 10.1007/s10549-012-2300-5. Epub 2012 Nov 4. Review.

PMID:
23124475
8.

Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.

Pi Y, Zhang L, Yang Q, Li B, Guo L, Fang C, Gao C, Wang J, Xiang J, Li J.

Cerebrovasc Dis. 2012;33(6):558-65. doi: 10.1159/000338781. Epub 2012 Jun 8.

9.

Correlation between LSP1 polymorphisms and the susceptibility to breast cancer.

Chen H, Qi X, Qiu P, Zhao J.

Int J Clin Exp Pathol. 2015 May 1;8(5):5798-802. eCollection 2015.

10.

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Antoniou AC, Sinilnikova OM, McGuffog L, Healey S, Nevanlinna H, Heikkinen T, Simard J, Spurdle AB, Beesley J, Chen X; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Neuhausen SL, Ding YC, Couch FJ, Wang X, Fredericksen Z, Peterlongo P, Peissel B, Bonanni B, Viel A, Bernard L, Radice P, Szabo CI, Foretova L, Zikan M, Claes K, Greene MH, Mai PL, Rennert G, Lejbkowicz F, Andrulis IL, Ozcelik H, Glendon G; OCGN, Gerdes AM, Thomassen M, Sunde L, Caligo MA, Laitman Y, Kontorovich T, Cohen S, Kaufman B, Dagan E, Baruch RG, Friedman E, Harbst K, Barbany-Bustinza G, Rantala J, Ehrencrona H, Karlsson P, Domchek SM, Nathanson KL, Osorio A, Blanco I, Lasa A, Benítez J, Hamann U, Hogervorst FB, Rookus MA, Collee JM, Devilee P, Ligtenberg MJ, van der Luijt RB, Aalfs CM, Waisfisz Q, Wijnen J, van Roozendaal CE; HEBON, Peock S, Cook M, Frost D, Oliver C, Platte R, Evans DG, Lalloo F, Eeles R, Izatt L, Davidson R, Chu C, Eccles D, Cole T, Hodgson S; EMBRACE, Godwin AK, Stoppa-Lyonnet D, Buecher B, Léoné M, Bressac-de Paillerets B, Remenieras A, Caron O, Lenoir GM, Sevenet N, Longy M, Ferrer SF, Prieur F; GEMO, Goldgar D, Miron A, John EM, Buys SS, Daly MB, Hopper JL, Terry MB, Yassin Y; Breast Cancer Family Registry, Singer C, Gschwantler-Kaulich D, Staudigl C, Hansen Tv, Barkardottir RB, Kirchhoff T, Pal P, Kosarin K, Offit K, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna M, Casella C, Imyanitov EN, Allavena A, Schmutzler RK, Versmold B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Deissler H, Fiebig B, Suttner C, Schönbuchner I, Gadzicki D, Caldes T, de la Hoya M, Pooley KA, Easton DF, Chenevix-Trench G; CIMBA.

Hum Mol Genet. 2009 Nov 15;18(22):4442-56. doi: 10.1093/hmg/ddp372. Epub 2009 Aug 5.

11.

The LSP1 rs3817198 T > C polymorphism contributes to increased breast cancer risk: a meta-analysis of twelve studies.

Tang J, Li H, Luo J, Mei H, Peng L, Li X.

Oncotarget. 2016 Sep 27;7(39):63960-63967. doi: 10.18632/oncotarget.11741. Review.

12.

Association between ERα gene Pvu II polymorphism and breast cancer susceptibility: A meta-analysis.

Zhang ZL, Zhang CZ, Li Y, Zhao ZH, Yang SE.

Medicine (Baltimore). 2018 Apr;97(17):e0317. doi: 10.1097/MD.0000000000010317. Review.

13.

Association of ALOX5AP rs10507391/SG13S114 A>T polymorphism with cerebral infarction in the Chinese population: a meta-analysis study.

Ke X, Wu X, Guo H, Li Q.

Int J Neurosci. 2015;125(10):726-32. doi: 10.3109/00207454.2014.967769. Epub 2014 Oct 22.

PMID:
25242267
14.

Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects.

Yao L, Yu X, Yu L.

Breast Cancer Res Treat. 2010 Jul;122(2):503-7. doi: 10.1007/s10549-009-0717-2. Epub 2010 Jan 6. Review.

PMID:
20052535
15.

RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies.

Yu KD, Yang C, Fan L, Chen AX, Shao ZM.

Breast Cancer Res Treat. 2011 Apr;126(2):365-71. doi: 10.1007/s10549-010-0937-5. Epub 2010 May 12.

PMID:
20461453
16.

The association between polymorphisms in the leptin receptor gene and risk of breast cancer: a systematic review and pooled analysis.

Wang LQ, Shen W, Xu L, Chen MB, Gong T, Lu PH, Tao GQ.

Breast Cancer Res Treat. 2012 Nov;136(1):231-9. doi: 10.1007/s10549-012-2228-9. Epub 2012 Sep 15.

PMID:
22983835
17.

Significant association between CYP1A1 T3801C polymorphism and cervical neoplasia risk: a systematic review and meta-analysis.

Xia L, Gao J, Liu Y, Wu K.

Tumour Biol. 2013 Feb;34(1):223-30. doi: 10.1007/s13277-012-0542-9. Epub 2012 Oct 4. Review.

PMID:
23055196
18.

Association of STAT4 gene rs7574865G > T polymorphism with ulcerative colitis risk: evidence from 1532 cases and 3786 controls.

Xu L, Dai WQ, Wang F, He L, Zhou YQ, Lu J, Xu XF, Guo CY.

Arch Med Sci. 2014 Jun 29;10(3):419-24. doi: 10.5114/aoms.2014.43735. Epub 2014 Jun 27. Review.

19.

Association between polymorphisms of the ataxia telangiectasia mutated gene and breast cancer risk: evidence from the current studies.

Lu PH, Wei MX, Si SP, Liu X, Shen W, Tao GQ, Chen MB.

Breast Cancer Res Treat. 2011 Feb;126(1):141-8. doi: 10.1007/s10549-010-1081-y. Epub 2010 Jul 28.

PMID:
20665102
20.

TNFalpha -308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls.

Fang F, Yao L, Yu XJ, Yu L, Wu Q, Yu L.

Breast Cancer Res Treat. 2010 Jul;122(1):267-71. doi: 10.1007/s10549-009-0698-1. Epub 2009 Dec 25.

PMID:
20035378

Supplemental Content

Support Center